Baxter International & Claris Injectables (2 phamaceutical products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Baxter International & Claris Injectables (2 phamaceutical products) General Information

Description

A portfolio pharmaceutical products rights in Deerfield, Illonois. The portfolio consists of rights to fluconazole in saline intravenous bags and milrinone in dextrose intravenous bags.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Deerfield, IL
  • United States
Primary Industry
Buildings and Property
Acquirer
Renaissance Lakewood
Corporate Office
  • Deerfield, IL
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baxter International & Claris Injectables (2 phamaceutical products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baxter International & Claris Injectables (2 phamaceutical products)‘s full profile, request access.

Request a free trial

Baxter International & Claris Injectables (2 phamaceutical products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baxter International & Claris Injectables (2 phamaceutical products)‘s full profile, request access.

Request a free trial

Baxter International & Claris Injectables (2 phamaceutical products) FAQs

  • Where is Baxter International & Claris Injectables (2 phamaceutical products) headquartered?

    Baxter International & Claris Injectables (2 phamaceutical products) is headquartered in Deerfield, IL.

  • What industry is Baxter International & Claris Injectables (2 phamaceutical products) in?

    Baxter International & Claris Injectables (2 phamaceutical products)’s primary industry is Buildings and Property.

  • Is Baxter International & Claris Injectables (2 phamaceutical products) a private or public company?

    Baxter International & Claris Injectables (2 phamaceutical products) is a Private company.

  • What is Baxter International & Claris Injectables (2 phamaceutical products)’s current revenue?

    The current revenue for Baxter International & Claris Injectables (2 phamaceutical products) is .

  • Who are Baxter International & Claris Injectables (2 phamaceutical products)’s investors?

    Baxter International and Claris Injectables have invested in Baxter International & Claris Injectables (2 phamaceutical products).

  • When was Baxter International & Claris Injectables (2 phamaceutical products) acquired?

    Baxter International & Claris Injectables (2 phamaceutical products) was acquired on 27-Jul-2017.

  • Who acquired Baxter International & Claris Injectables (2 phamaceutical products)?

    Baxter International & Claris Injectables (2 phamaceutical products) was acquired by Renaissance Lakewood.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process